** BofA Global Research downgrades health insurer Centene CNC.N to "underperform" from "neutral", trims PT to $30 from $52
** Medicaid and Affordable Care Act $(ACA)$ exchange markets are slowing due to the new Reconciliation Bill, and there's a strong chance that enhanced government subsidies for ACA coverage will expire after 2025, BofA analysts say
** Brokerage expects at least $2.75 per share of pressure from the ACA exchanges, plus higher costs in Medicaid
** Membership declines driven by the new legislation are expected to slow CNC’s revenue growth through 2029, while shifting insurance risks and potential Medicaid rate cuts will make it more difficult for the company to restore normal profit margins, BofA analysts say
** As of last close, CNC stock down 50.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.